Medicine & Life Sciences
Parkinson Disease
100%
Parkinsonian Disorders
51%
Progressive Supranuclear Palsy
32%
Systematic Reviews
25%
Arteriovenous Malformations
25%
Stroke
23%
Scotland
18%
Multiple System Atrophy
16%
Disease Progression
15%
Confidence Intervals
14%
Levodopa
14%
Population
14%
Multiple Sclerosis
12%
Parkinson Disease, Familial, Type 1
12%
Monoamine Oxidase Inhibitors
11%
Dementia
11%
Dopamine Agonists
11%
Monoamine Oxidase
11%
Brain
11%
Mental Status and Dementia Tests
11%
Conservative Treatment
10%
Glatiramer Acetate
10%
Incidence
10%
Intracranial Hemorrhages
9%
Therapeutics
9%
Odds Ratio
9%
Meta-Analysis
8%
Cohort Studies
8%
Hemorrhage
8%
ocrelizumab
8%
Randomized Controlled Trials
8%
Genome
8%
Interferon-beta
8%
Clinical Trials
8%
Cognitive Dysfunction
7%
Central Nervous System Cavernous Hemangioma
7%
Parkinson Disease 10
7%
Institutionalization
7%
Seizures
7%
propylene diquat
6%
Network Meta-Analysis
6%
Anticoagulants
6%
Biomarkers
6%
Chronic Progressive Multiple Sclerosis
6%
Glucosylceramidase
6%
Mortality
6%
Death Certificates
6%
Activities of Daily Living
6%
Infectious Mononucleosis
6%
Survival
6%